N/A
Completed N=32
Smart-phone Application to Promote Medication Adherence in Adolescents and Young Adults (AYA) With Cancer
Source: ClinicalTrials.gov NCT01618344 ↗Enrolled (actual)
32
Serious AEs
0.0%
Results posted
Nov 2017
Primary outcomePrimary: Feasibility and Acceptability of Using a Smart-phone Medication Reminder Application to Promote Adherence to Oral Medications by AYA With Cancer. — 21; 13 Participants
Summary
To explore use of a smart-phone medication reminder application to promote adherence to oral medications by AYA with cancer.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility and Acceptability of Using a Smart-phone Medication Reminder Application to Promote Adherence to Oral Medications by AYA With Cancer. |
21; 13 | — |
Eligibility Criteria
Inclusion criteria
1)15-29 year olds receiving treatment for any type of cancer, either primary or recurrent/relapsed disease.
- Patient has completed at least one month of therapy
3)Patient is expected to remain on therapy for 3 month duration of study
- Patient has an iPhone, iPad, or iTouch running iOS 4.0 or later
- Patient is willing to use a smart-phone medication reminder application-
Exclusion Criteria
1)Patients who are unable to speak/read/write English as required for use of smart-phone medication reminder application and completion of study measures.
Data sourced from ClinicalTrials.gov (NCT01618344). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.